Narya Capital — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Kriya Therapeuticskriyatherapeutics.com in 𝕏Jun 2021 · $1.2B

Kriya Therapeutics is a biopharmaceutical company that develops and manufactures one-time gene therapies aimed at treating prevalent chronic diseases.

BiotechHealthtechMorrisville, US

Shankar Ramaswamy(Co-Founder, Chairman & CEO)Roger Jeffs(Co-Founder & Vice Chairman)Fraser Wright(Scientific Co-Founder & Chief Gene Therapy Officer)Michele Stone(Chief Scientific Officer)Katherine Eade(Chief Legal Officer)Britt Petty(Chief Manufacturing Officer)

Co-investorsPatient Square Capital Premji Invest Amplo Ventures Bluebird Ventures Foresite Capital JDRF T1D Fund +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.